FUJIFILM Cellular Dynamics to build $21M iPS cell production facility in Madison

FUJIFILM Cellular Dynamics, Inc. announced an investment of about $21 million to open a new cGMP-compliant production facility in Madison, Wisconsin, with the goal to begin operations by March 2020. The facility will support internal cell therapeutics and serve as a CDMO for iPS cell products.

“To meet the growing demand for FCDI's iPS cell platform, the state-of-the-art production facility will have a flexible cell culturing design to serve production requirements of both industrial quantities of cells, and small, diverse batches.”fujifilmcdi.com

• 1 source
• fujifilmcdi.comFUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy ApplicationsJan 3, 2019

Summarized from public sources; check the original articles before acting on it.